It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hydrogen peroxide (H2O2)-based products are effective in tooth whitening; however, their safety is controversial as they may harm patient tissues/cells. These effects are suggested to be concentration-dependent; nonetheless, to date, there are no reports on H2O2-mediated oxidative damage in the gingival tissue, and neither whether this can be detected in gingival crevicular fluid (GCF) samples. We hypothesize that H2O2 whitening products may cause collateral oxidative tissue damage following in office application. Therefore, H2O2 and nitric oxide (NO) levels were investigated in GCF samples obtained from patients undergoing dental bleaching with H2O2 at different concentrations, in a randomized, double-blind, split-mouth clinical trial. A proteomic analysis of these samples was also performed. H2O2-based whitening products promoted inflammation which was detected in GCF samples and lasted for longer following 35% H2O2 bleaching. This included time-dependent changes in NO levels and in the abundance of proteins associated with NO synthesis, oxidative stress, neutrophil regulation, nucleic acid damage, cell survival and/or tissue regeneration. Overall, H2O2-based products used in office promote inflammation irrespective of their concentration. As the inflammation caused by 35% H2O2 is longer, patients may benefit better from using lower concentrations of this bleaching product, as they may result in less tissue damage.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Universidade Ceuma, Programa de Pós-graduação, São Luís, Brazil (GRID:grid.442152.4) (ISNI:0000 0004 0414 7982)
2 Universidade de São Paulo, Departamento de Farmacologia, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)
3 The University of Western Ontario, School of Dentistry and Department of Biochemistry, Schulich School of Medicine & Dentistry, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
4 Universidade Ceuma, Programa de Pós-graduação, São Luís, Brazil (GRID:grid.442152.4) (ISNI:0000 0004 0414 7982); The University of Western Ontario, School of Dentistry and Department of Biochemistry, Schulich School of Medicine & Dentistry, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Centro Universitário das Faculdades Associadas – UNIFAE, São João da Boa Vista, Brazil (GRID:grid.39381.30)